# Sionna Therapeutics Reports $0.72 Net Loss Per Share for Q3

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/54087
Published: 2026-11-11T14:33:44.000Z
Updated: 2026-11-11T14:33:44.000Z
Section: Business

> The figure covers both basic and diluted per-share results. The quarter ended Sept. 30, 2026.

Sionna Therapeutics recorded net loss per share, basic and diluted, of $0.72 for the third quarter ended Sept. 30, 2026. The company’s results release is dated Nov. 10, 2026.